Ribon Therapeutics (@RibonTx) / X

Heike Keilhack (@haxe73) / X

Ribon Therapeutics

Forced Self-Modification Assays as a Strategy to Screen MonoPARP Enzymes - Tim J. Wigle, W. David Church, Christina R. Majer, Kerren K. Swinger, Demet Aybar, Laurie B. Schenkel, Melissa M. Vasbinder, Arne

Ribon Therapeutics (@RibonTx) / X

Investors – Ribon Therapeutics

New directions in poly(ADP‐ribose) polymerase biology - Bock - 2016 - The FEBS Journal - Wiley Online Library

Ribon Therapeutics (@RibonTx) / X

Ribon Therapeutics (@RibonTx) / X

Investors – Ribon Therapeutics